Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRL

Charles River Laboratories International Inc

Jun 10 • 04:00PM ET

186.29

-3.56 -1.88 %

Healthcare • Diagnostics & Research • USA • Mid • NYSE

Peers: ICLR IQV MEDP LH DGX TMO A DHR WAT BIO

| Held by: VTI VOO RSP VB VBR IVV SPY IBB XLV DFAT

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-3.76	Insider Own	1.31%	Shs Outstand	48.17M	Perf Week	3.57%
Market Cap	8.97B	Forward P/E	15.11	EPS next Y	12.33	Insider Trans	-0.06%	Shs Float	47.54M	Perf Month	10.58%
Enterprise Value	11.89B	PEG	1.59	EPS next Q	2.73	Inst Own	121.08%	Short Float	8.20%	Perf Quarter	10.29%
Income	-184.65M	P/S	2.23	EPS this Y	7.92%	Inst Trans	11.60%	Short Ratio	4.45	Perf Half Y	-0.44%
Sales	4.03B	P/B	3.05	EPS next Y	11.13%	ROA	-2.41%	Short Interest	3.90M	Perf YTD	-6.61%
Book/sh	61.05	P/C	46.31	EPS next 5Y	9.49%	ROE	-6.02%	52W High	228.88 -18.61%	Perf Year	23.37%
Cash/sh	4.02	P/FCF	22.93	EPS past 3/5Y	- -	ROIC	-3.08%	52W Low	143.06 30.22%	Perf 3Y	-5.76%
Dividend Est.	-	EV/EBITDA	13.63	Sales past 3/5Y	0.33% 6.55%	Gross Margin	31.25%	Volatility	4.51% 5.17%	Perf 5Y	-47.49%
Dividend TTM	-	EV/Sales	2.95	EPS Y/Y TTM	-492.25%	Oper. Margin	12.98%	ATR (14)	8.58	Perf 10Y	119.86%
Dividend Ex-Date	-	Quick Ratio	1.03	Sales Y/Y TTM	0.11%	Profit Margin	-4.59%	RSI (14)	59.68	Recom	1.85
Dividend Gr. 3/5Y	- -	Current Ratio	1.36	EPS Q/Q	-160.54%	SMA20	9.58%	Beta	1.42	Target Price	217.79
Payout	-	Debt/Eq	1.04	Sales Q/Q	1.18%	SMA50	7.73%	Rel Volume	0.82	Prev Close	189.85
Employees	19700	LT Debt/Eq	1.04	Earnings	May 07 BMO	SMA200	5.06%	Avg Volume	875.93K	Price	186.29
IPO	Jun 23, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% 1.88%	Trades		Volume	715,813	Change	-1.88%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)